Rukobia (Fostemsavir) for HIV

Overview
Rukobia is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretrovirals. Rukobia is approved for heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations. Rukobiah is also referred to by its drug name, Fostemsavir. Rukobia is an antiviral medication known as an HIV-1 gp120-directed attachment inhibitor. Rukobia is believed to work by preventing HIV from replicating in cells.

How do I take it?
Rukobia is taken twice daily. Rukobia comes in extended-release tablet form.

Side effects
The FDA-approved label for Rukobiah lists common side effects including nausea. Rare but serious side effects listed for Rukobia include immune reconstitution syndrome (where the immune system produces an inflammatory response that makes symptoms of infection worse) and liver and heart issues.

For more details about this treatment, visit:

Rukobia — ViiV Healthcare

Overview of HIV Treatments — HIV.gov